reviewThe Annual Review of Pharmacology and ToxicologyJan 8, 2010Closed access

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

Ionis Pharmaceuticals (United States)

PubMed
Indexed incrossrefpubmed

Abstract

Dramatic advances in understanding of the roles RNA plays in normal health and disease have greatly expanded over the past 10 years and have made it clear that scientists are only beginning to comprehend the biology of RNAs. It is likely that RNA will become an increasingly important target for therapeutic intervention; therefore, it is important to develop strategies for therapeutically modulating RNA function. Antisense oligonucleotides are perhaps the most direct therapeutic strategy to approach RNA. Antisense oligonucleotides are designed to bind to the target RNA by well-characterized Watson-Crick base pairing, and once bound to the target RNA, modulate its function through a variety of postbinding…

Citation impact

1,338
total citations
FWCI
32.53
Percentile
100%
References
231
Citations per year

Authors

2

Topics & keywords

Keywords
  • RNA
  • Oligonucleotide
  • Computational biology
  • Biology
  • Antisense RNA
  • Function (biology)
  • RNA interference
  • Cell biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.